Compare Invent Medic Sweden AB with Similar Stocks
Stock DNA
Pharmaceuticals & Biotechnology
SEK 23 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
0.24
-96.69%
4.21
Revenue and Profits:
Net Sales:
2 Million
(Quarterly Results - Dec 2025)
Net Profit:
-1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.84%
0%
-15.84%
6 Months
-3.95%
0%
-3.95%
1 Year
-71.61%
0%
-71.61%
2 Years
-80.7%
0%
-80.7%
3 Years
-57.09%
0%
-57.09%
4 Years
-96.93%
0%
-96.93%
5 Years
-97.93%
0%
-97.93%
Invent Medic Sweden AB for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
37.24%
EBIT Growth (5y)
11.05%
EBIT to Interest (avg)
-11.44
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.10
Sales to Capital Employed (avg)
1.36
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.89
EV to EBIT
-3.23
EV to EBITDA
-3.23
EV to Capital Employed
3.90
EV to Sales
2.64
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-120.80%
ROE (Latest)
-91.47%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY
Dec'25
Dec'24
Change(%)
Net Sales
1.80
2.10
-14.29%
Operating Profit (PBDIT) excl Other Income
-0.90
-1.80
50.00%
Interest
0.10
0.90
-88.89%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-1.10
-2.50
56.00%
Operating Profit Margin (Excl OI)
-536.70%
-878.90%
34.22%
USD in Million.
Net Sales
YoY Growth in quarter ended Dec 2025 is -14.29% vs 5.00% in Dec 2024
Consolidated Net Profit
YoY Growth in quarter ended Dec 2025 is 56.00% vs -13.64% in Dec 2024
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
7.40
7.30
1.37%
Operating Profit (PBDIT) excl Other Income
-4.80
-6.30
23.81%
Interest
0.30
1.40
-78.57%
Exceptional Items
0.00
0.00
Consolidate Net Profit
-5.20
-7.70
32.47%
Operating Profit Margin (Excl OI)
-645.90%
-894.60%
24.87%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 1.37% vs 8.96% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 32.47% vs 9.41% in Dec 2024
About Invent Medic Sweden AB 
Invent Medic Sweden AB
Pharmaceuticals & Biotechnology
Invent Medic Sweden AB is a Sweden-based company, which is primarily engaged in the healthcare industry. The Company manufactures TVS that is a medical device for non-surgical treatment of female stress urinary incontinence. The product has a similar mechanism of action as the surgical treatment method. Effect time-mechanism is based on two parts with the upper annular support incontinence in the upper part of the urethra while the lower part comprises an external fixation plate that ensures that the TVS placed correctly. Following the introduction of the product is the labia range around the reference part to ensure that the supporting part is always positioned correctly in order to exert its effect.






